Ondas stock wobbles on heavy volume as a January share issuance nears
29 December 2025
1 min read

Ondas stock wobbles on heavy volume as a January share issuance nears

NEW YORK, December 29, 2025, 2:33 PM ET — Regular session

  • Ondas shares down about 0.5% at $8.44 in afternoon trade, with volume topping 22 million shares.
  • The company has flagged another share issuance due Jan. 5 tied to a recent notes-and-warrants exchange. 1
  • A prospectus supplement registers shares from that exchange for resale, with daily selling limits tied to trading volume. 2

Shares of Ondas Holdings Inc were down about 0.5% at $8.44 in Monday afternoon trading, sliding with a broader pullback in drone and defense-tech names.

The dip comes as investors size up an early-January stock issuance tied to a recent exchange deal that increased the number of shares available for resale in the market. 1

It also lands days before year-end results will absorb an accounting hit. Ondas said it expects a one-time, non-cash charge of about $56.6 million in the quarter ending Dec. 31 — an expense that does not reduce cash on hand. 1

In a Dec. 17 current report, Ondas said holders of convertible promissory notes and warrants at its Ondas Autonomous Systems subsidiary swapped those securities into Ondas shares. Convertible notes are debt that can convert into equity. 1

Ondas said seven of the 11 holders elected to defer their closing until Jan. 5, when the company expects to issue about 2.39 million additional shares. Privet Ventures, an entity affiliated with CEO Eric Brock, is set to receive about 1.15 million shares at that closing, the filing showed. 1

A related prospectus supplement — a document that allows existing holders to resell stock — said selling shareholders face daily limits. Under the “trading limitation,” they cannot sell more than 5% of the stock’s average daily volume, based on the prior 10 trading sessions. 2

Ondas said it will not receive proceeds from any sales by those shareholders. 2

The stock traded between $8.22 and $8.66 on Monday after opening at $8.30, and had seen more than 22 million shares change hands by 2:33 p.m. ET.

Peers were also lower. AeroVironment slipped 2.6%, Red Cat fell 3.9% and Kratos Defense & Security Solutions eased 0.7%.

Ondas sells autonomous drone and ground robotics systems through its Ondas Autonomous Systems unit and private wireless equipment through Ondas Networks, targeting defense, security and critical infrastructure customers. 2

The company has expanded its robotics footprint through deals, including its acquisition of Israeli rugged ground-robot maker Roboteam this month. “The Roboteam acquisition adds proven ground robotic capabilities to our autonomous systems portfolio,” Brock said in a Dec. 17 release. 3

Traders will watch for updates on how quickly the newly issued shares are resold ahead of the Jan. 5 closing, and whether the stock holds Monday’s $8.22 low as a near-term technical floor. Ondas lists no upcoming events on its investor relations calendar, leaving regulatory filings as the next signpost for the timing of its full-year results. 4

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
NBIS stock slides after Nebius CEO files to sell shares as AI trade cools
Previous Story

NBIS stock slides after Nebius CEO files to sell shares as AI trade cools

Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears
Next Story

Bristol Myers Squibb stock slips today as year-end trading thins and dividend date nears

Go toTop